
Advancing science.
Building Partnerships.
Real-world impact.
For more than 40 years, AlphaMed has helped bring advances in research into clinical practice. We convene expertise, build strategic partnerships, and support real-world solutions that expand prevention, early detection, evidence-based care, and patient support.
Turning evidence into impact
AlphaMed connects science with strategy to advance cancer prevention, improve care, and expand access.
Evidence
Identifying proven approaches, emerging opportunities, and gaps that need attention
Partnership
Bringing the right people, expertise, and perspectives together to build shared priorities
Implementation
Supporting education, navigation, and care strategies that put evidence into practice
Impact
Helping more people benefit from prevention, screening, timely follow-up, and high-quality care
STRATEGIC FOCUS: CERVICAL CANCER ELIMINATION
Prevention is only powerful when it is accessible. Cervical cancer can be prevented through HPV vaccination and, when detected early, treated effectively. Yet prevention can fall short when vaccination is out of reach, screening is missed, follow-up is delayed, or access to treatment is limited.
AlphaMed brings together clinical, community, and industry partners to strengthen the full pathway, from prevention and screening through follow-up and care, particularly in rural, underserved, and safety-net communities.

COLLABORATION IS HOW PROGRESS HAPPENS
No single organization can eliminate cervical cancer or close persistent gaps in cancer care alone. Progress depends on connecting scientific advances with clinical workflows, community priorities, patient education, and sustainable approaches to implementation.
AlphaMed works across these settings to foster partnerships and advance practical solutions that strengthen prevention, screening, follow-up, and care, particularly in rural, underserved, and safety-net communities.
The strongest solutions are built where scientific evidence, clinical reality, community priorities, and sustainable implementation meet.

Shared Purpose. Distinct Roles. Greater Impact.

AlphaMed was a driving force behind the creation of the Society for Translational Oncology (STO), an independent nonprofit advancing evidence-based oncology education and implementation.
Today, STO provides practical, independent education for oncology professionals and the broader cancer community, while AlphaMed convenes cross-sector partners to develop strategies and solutions that move promising evidence into practice. Together, we help turn knowledge into better cancer care.
A Legacy of Evidence
AlphaMed founded and published The Oncologist, STEM CELLS, and STEM CELLS Translational Medicine, journals that helped shape oncology, regenerative medicine, and translational research. Now published by Oxford University Press, these journals reflect AlphaMed’s enduring belief that rigorous science should lead to better patient care.



What can we build together?
Progress in cancer prevention and care starts with new ideas and strong partnerships. If you’re exploring an innovative approach, building a collaboration, or working to bring promising evidence into practice, let’s connect and explore what we can make possible together.
